Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Arecor Therapeutics PLC ( (GB:AREC) ) has issued an announcement.
Arecor Therapeutics has entered into a collaboration with a major global pharmaceutical company to develop a novel formulation of the partner’s proprietary product using Arecor’s Arestat™ technology. This partnership, which is fully funded by the partner, underscores Arecor’s leadership in drug delivery and formulation innovation, potentially leading to future licensing opportunities and enhancing its market positioning.
More about Arecor Therapeutics PLC
Arecor Therapeutics plc is a biopharmaceutical company focused on transforming patient care by enhancing existing therapeutic products. Utilizing its proprietary technology platform, Arestat™, Arecor develops an internal portfolio of products in diabetes and other areas, and collaborates with leading pharmaceutical and biotechnology companies to deliver innovative therapeutic solutions.
YTD Price Performance: -33.33%
Average Trading Volume: 11,996
Technical Sentiment Signal: Buy
Current Market Cap: £18.5M
See more data about AREC stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue